Clinical trial
Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus
NCT00387309 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00387309 |
|---|---|
| Title | Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus |
| Official title | A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Intravenous Methylnaltrexone (MOA-728) for the Treatment of Post Operative Ileus. |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Post Operative Bowel Dysfunction |
| Intervention type | Drug |
| Interventions | Methylnaltrexone (MOA-728) |
| Enrollment | 495 |
| Start date | Dec 1, 2006 |
| Completion | Nov 1, 2007 |
| First posted | Oct 13, 2006 |
| Last update posted | Nov 25, 2019 |
| Countries | Australia, Germany, Hungary, Italy, Poland, Romania, Serbia and Montenegro, South Africa, South Korea, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: